Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Clinical Trials in Boston, Massachusetts

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer